Source: Health Products Regulatory Authority (IE) Revision Year: 2022 Publisher: KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Loxentia 20mg hard gastro-resistant capsule.
Pharmaceutical Form |
---|
Hard gastro-resistant capsule. White to almost white pellets in a hard gelatine capsule size 4 (average length: 14.4 mm). The capsule body and cap are light blue. The capsule body is imprinted with 20 in black. |
Each hard gastro-resistant capsule contains 20 mg duloxetine (as duloxetine hydrochloride).
Excipient with known effect: sucrose.
Each 20 mg hard gastro-resistant capsule contains up to 29 mg sucrose.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Duloxetine |
Duloxetine is a combined serotonin (5-HT) and noradrenaline (NA) reuptake inhibitor. It weakly inhibits dopamine reuptake with no significant affinity for histaminergic, dopaminergic, cholinergic and adrenergic receptors. |
List of Excipients |
---|
Capsule contents: Sugar spheres (sucrose, maize starch) Capsule shell: Gelatin |
Blisters (OPA/Alu/[HDPE/PE + DES of CaO/HDPE] foil – Alu/PE foil): 7, 10, 14, 28, 30, 56, 60, 90 and 100 hard gastro-resistant capsules, in a box.
Not all pack sizes may be marketed.
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
PA1347/051/001
Date of first authorisation: 15th of May 2015
Date of last renewal: 17th February 2020
Drug | Countries | |
---|---|---|
LOXENTIA | Finland, Ireland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.